Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
ADGM Quote, Financials, Valuation and Earnings
Last price:
$1.06
Seasonality move
:
-9.45%
Day range:
$0.98 - $1.09
52-week range:
$0.63 - $2.87
Dividend yield:
0%
P/E ratio:
218.00x
P/S ratio:
118.08x
P/B ratio:
1.99x
Volume:
1M
Avg. volume:
235.7K
1-year change:
9.22%
Market cap:
$22.3M
Revenue:
$602K
EPS (TTM):
-$5.28
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.24 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$17.8M | -$0.08 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
|
NPCE
NeuroPace, Inc.
|
$24.6M | -$0.19 | 13.69% | -5.76% | $19.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings, Inc.
|
$1.06 | $4.00 | $22.3M | 218.00x | $0.00 | 0% | 118.08x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$4.98 | -- | $4.8M | -- | $0.00 | 0% | 9.90x |
|
LAB
Standard BioTools, Inc.
|
$1.47 | $1.65 | $565.3M | -- | $0.00 | 0% | 4.32x |
|
LNSR
LENSAR, Inc.
|
$12.01 | $15.00 | $143.5M | -- | $0.00 | 0% | 2.41x |
|
MOVE
Movano, Inc.
|
$7.97 | $30.00 | $6.7M | -- | $0.00 | 0% | 12.06x |
|
NPCE
NeuroPace, Inc.
|
$16.19 | $19.25 | $539.3M | -- | $0.00 | 0% | 5.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 2.155 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 2.628 | 67.05% | 0.29x |
|
NPCE
NeuroPace, Inc.
|
79.36% | 0.212 | 20.74% | 3.82x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
|
NPCE
NeuroPace, Inc.
|
$21.2M | -$2.6M | -27.09% | -149.8% | -9.51% | -$2M |
Adagio Medical Holdings, Inc. vs. Competitors
-
Which has Higher Returns ADGM or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -- compared to Adagio Medical Holdings, Inc.'s net margin of -269.38%. Adagio Medical Holdings, Inc.'s return on equity of -340.49% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About ADGM or INBS?
Adagio Medical Holdings, Inc. has a consensus price target of $4.00, signalling upside risk potential of 300%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 2309.64%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Adagio Medical Holdings, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Adagio Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings, Inc.1 0 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is ADGM or INBS More Risky?
Adagio Medical Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or INBS?
Adagio Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or INBS?
Adagio Medical Holdings, Inc. quarterly revenues are --, which are smaller than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Adagio Medical Holdings, Inc.'s net income of -$10.1M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Adagio Medical Holdings, Inc.'s price-to-earnings ratio is 218.00x while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings, Inc. is 118.08x versus 9.90x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M INBSIntelligent Bio Solutions, Inc.9.90x -- $1.1M -$3M
-
Which has Higher Returns ADGM or LAB?
Standard BioTools, Inc. has a net margin of -- compared to Adagio Medical Holdings, Inc.'s net margin of -162.05%. Adagio Medical Holdings, Inc.'s return on equity of -340.49% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About ADGM or LAB?
Adagio Medical Holdings, Inc. has a consensus price target of $4.00, signalling upside risk potential of 300%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 5.44%. Given that Adagio Medical Holdings, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings, Inc.1 0 0 LABStandard BioTools, Inc.1 2 0 -
Is ADGM or LAB More Risky?
Adagio Medical Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock ADGM or LAB?
Adagio Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LAB?
Adagio Medical Holdings, Inc. quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Adagio Medical Holdings, Inc.'s net income of -$10.1M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Adagio Medical Holdings, Inc.'s price-to-earnings ratio is 218.00x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings, Inc. is 118.08x versus 4.32x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M LABStandard BioTools, Inc.4.32x -- $19.6M -$31.7M
-
Which has Higher Returns ADGM or LNSR?
LENSAR, Inc. has a net margin of -- compared to Adagio Medical Holdings, Inc.'s net margin of -25.94%. Adagio Medical Holdings, Inc.'s return on equity of -340.49% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About ADGM or LNSR?
Adagio Medical Holdings, Inc. has a consensus price target of $4.00, signalling upside risk potential of 300%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that Adagio Medical Holdings, Inc. has higher upside potential than LENSAR, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than LENSAR, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings, Inc.1 0 0 LNSRLENSAR, Inc.0 2 0 -
Is ADGM or LNSR More Risky?
Adagio Medical Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock ADGM or LNSR?
Adagio Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LNSR?
Adagio Medical Holdings, Inc. quarterly revenues are --, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. Adagio Medical Holdings, Inc.'s net income of -$10.1M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Adagio Medical Holdings, Inc.'s price-to-earnings ratio is 218.00x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings, Inc. is 118.08x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M LNSRLENSAR, Inc.2.41x -- $14.3M -$3.7M
-
Which has Higher Returns ADGM or MOVE?
Movano, Inc. has a net margin of -- compared to Adagio Medical Holdings, Inc.'s net margin of -5036.25%. Adagio Medical Holdings, Inc.'s return on equity of -340.49% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About ADGM or MOVE?
Adagio Medical Holdings, Inc. has a consensus price target of $4.00, signalling upside risk potential of 300%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3664.12%. Given that Movano, Inc. has higher upside potential than Adagio Medical Holdings, Inc., analysts believe Movano, Inc. is more attractive than Adagio Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings, Inc.1 0 0 MOVEMovano, Inc.0 0 0 -
Is ADGM or MOVE More Risky?
Adagio Medical Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or MOVE?
Adagio Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or MOVE?
Adagio Medical Holdings, Inc. quarterly revenues are --, which are smaller than Movano, Inc. quarterly revenues of $80K. Adagio Medical Holdings, Inc.'s net income of -$10.1M is lower than Movano, Inc.'s net income of -$4M. Notably, Adagio Medical Holdings, Inc.'s price-to-earnings ratio is 218.00x while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings, Inc. is 118.08x versus 12.06x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M MOVEMovano, Inc.12.06x -- $80K -$4M
-
Which has Higher Returns ADGM or NPCE?
NeuroPace, Inc. has a net margin of -- compared to Adagio Medical Holdings, Inc.'s net margin of -12.78%. Adagio Medical Holdings, Inc.'s return on equity of -340.49% beat NeuroPace, Inc.'s return on equity of -149.8%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M NPCENeuroPace, Inc.77.39% -$0.11 $89.7M -
What do Analysts Say About ADGM or NPCE?
Adagio Medical Holdings, Inc. has a consensus price target of $4.00, signalling upside risk potential of 300%. On the other hand NeuroPace, Inc. has an analysts' consensus of $19.25 which suggests that it could grow by 18.9%. Given that Adagio Medical Holdings, Inc. has higher upside potential than NeuroPace, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than NeuroPace, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings, Inc.1 0 0 NPCENeuroPace, Inc.7 0 0 -
Is ADGM or NPCE More Risky?
Adagio Medical Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeuroPace, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or NPCE?
Adagio Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroPace, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings, Inc. pays -- of its earnings as a dividend. NeuroPace, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or NPCE?
Adagio Medical Holdings, Inc. quarterly revenues are --, which are smaller than NeuroPace, Inc. quarterly revenues of $27.4M. Adagio Medical Holdings, Inc.'s net income of -$10.1M is lower than NeuroPace, Inc.'s net income of -$3.5M. Notably, Adagio Medical Holdings, Inc.'s price-to-earnings ratio is 218.00x while NeuroPace, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings, Inc. is 118.08x versus 5.44x for NeuroPace, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M NPCENeuroPace, Inc.5.44x -- $27.4M -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
